Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03661112 · ClinicalTrials.gov registry record
Wrist-based Blood Pressure Monitoring Study
A clinical trial, sponsored by Scripps Translational Science Institute.
- Completed
- Registry status
- 50
- Enrollment target
NCT03661112: Completed study, sponsored by Scripps Translational Science Institute.
NCT03661112 is a clinical trial that has completed, run by Scripps Translational Science Institute. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03661112 has completed, sponsored by Scripps Translational Science Institute.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
To observe blood pressure variation in various real-world settings
Primary Outcome
The primary endpoint for this study is assessing variability in blood pressure measurements (both systolic and diastolic). Blood pressure measurements will be sought over the course of 4 weeks during the following activities: 1. During waking hours (several times a day for at least 2 days out of the week) 2. Orthostatic maneuvers (seated and then 1 minute after standing up) 3. At times of stress and relaxation.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-05-07 |
| Est. Completion | 2018-12-31 |
What the finished NCT03661112 record still lists
NCT03661112 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03661112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03661112 about?
NCT03661112 is a clinical study titled "Wrist-based Blood Pressure Monitoring Study". To observe blood pressure variation in various real-world settings
What is the current status of trial NCT03661112?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2018-05-07. Estimated completion is 2018-12-31.
Who is sponsoring clinical trial NCT03661112?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI